An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease

METHODS: In a 12-week, open-label, exploratory clinical trial, 126 NAFLD patients were randomly divided into the GLS group (lifestyle intervention plus GLS) or the polyene phosphatidylcholine (PPC) group (lifestyle intervention plus PPC). Random numbers generated by DPS software were used in combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Luo, Jian-Xing, Li, Yan-Ge, Fu, Hong-Fang, Yang, Fang, Hu, Xiao-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967510/
https://www.ncbi.nlm.nih.gov/pubmed/35368766
http://dx.doi.org/10.1155/2022/4583645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967510/
https://www.ncbi.nlm.nih.gov/pubmed/35368766
http://dx.doi.org/10.1155/2022/4583645

Ejemplares similares